Related Experiment Video
Updated: Sep 13, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Management of pulmonary and cardiovascular comorbidities in rheumatological diseases]
P Xanthouli1,2, A Schatz3, R Bergner4
1Zentrum für pulmonale Hypertonie, Thoraxklinik am Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
Abstract:
Pulmonary, renal and cardiovascular diseases as well as osteoporosis, must always be considered in the treatment of patients with inflammatory rheumatic diseases. Regardless of whether they are an organ manifestation of the underlying rheumatic disease, a medication side effect or a comorbidity, these diseases have a decisive influence on morbidity, mortality and the treatment decisions. This article is part 1 of a CME article containing information on current diagnostic and therapeutic recommendations for pulmonary and cardiovascular comorbidities. The newest American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) guidelines on cardiovascular manifestations are discussed and the guideline recommendations as well as insights into current therapeutic studies on the diagnostics and treatment of frequent pulmonary comorbidities in inflammatory rheumatic diseases are presented.
Related Concept Videos
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Management Using Bronchodilators and Corticosteroids
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

